Dean Schwartz | LifeSci Advisors, IR |
Steven Shallcross | CEO and CFO |
Manel Cascallo | General Director of VCN & European Operations |
Jim Molloy | Alliance Global Partners |
Leland Gershell | Oppenheimer |
Greetings, and welcome to Synthetic Biologics' First Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Dean Schwartz of LifeSci Advisors.